E
Epitomee Medical Ltd
TASE:EPIT
Epitomee Medical Ltd
TASE:EPIT
Price:
922.2
ILS
-0.87%
Market Closed
Market Cap:
₪272.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Epitomee Medical Ltd
TASE:EPIT
|
IL |
|
P
|
Precious Shipping PCL
SET:PSL
|
TH |
|
C
|
Changchun Engley Automobile Industry Co Ltd
SSE:601279
|
CN |
|
Clene Inc.
NASDAQ:CLNN
|
US |
|
Melexis NV
OTC:MLXSF
|
BE |
|
Bajaj Finance Ltd
NSE:BAJFINANCE
|
IN |
|
Radius Global Infrastructure Inc
F:R13
|
US |
|
Imeik Technology Development Co Ltd
SZSE:300896
|
CN |
|
B
|
Beijing Tricolor Technology Co Ltd
SSE:603516
|
CN |
|
Fujian Wanchen Biotechnology Co Ltd
SZSE:300972
|
CN |
|
Jiangsu Xiehe Electronic Co Ltd
SSE:605258
|
CN |
|
Gildan Activewear Inc
TSX:GIL
|
CA |
|
Capita PLC
LSE:CPI
|
UK |
|
Mandarake Inc
TSE:2652
|
JP |
|
A
|
Asia Pacific Investama Tbk PT
IDX:MYTX
|
ID |
|
A
|
Amway (Malaysia) Holdings Bhd
KLSE:AMWAY
|
MY |
|
C
|
CTI Biopharma Corp
F:CEPS
|
US |
Relative Value
The Relative Value of one EPIT stock under the Base Case scenario is hidden ILS. Compared to the current market price of 922.2 ILS, Epitomee Medical Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EPIT Relative Value
HIDDEN
Multiples Across Competitors
EPIT Competitors Multiples
Epitomee Medical Ltd Competitors
Epitomee Medical Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
E
|
Epitomee Medical Ltd
TASE:EPIT
|
272.2m ILS | 0 | -59.9 | -47.4 | -36.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
180.7B USD | 4.1 | 27.7 | 15.9 | 21.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
167.6B USD | 16.6 | 58.7 | 44.5 | 54.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.2B USD | 5 | 38.7 | 19.8 | 24 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.1B USD | 3.1 | 24.1 | 13.3 | 19.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
101.1B USD | 5 | 34.9 | 20.5 | 27.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.4B EUR | 1.8 | 19.6 | 11 | 15.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.4B USD | 7.8 | 44.2 | 24.3 | 26.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.5B USD | 10.6 | 42.9 | 30.4 | 33.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.4B USD | 2 | 25.3 | 10 | 16.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.2B USD | 6.2 | 22.4 | 15.7 | 17.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
